Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision label updates from v3.7.1 to v3.7.2.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study page now renders a 403 Forbidden error with HTML indicating restricted access, and the visible study content appears removed or hidden as a result.SummaryDifference20%

- Check42 days agoChange DetectedThe page now displays a new revision tag, updating from v3.6.6 to v3.7.0, indicating an update to the page rendering/version. This change does not modify study content or user-facing data.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page shows a new revision tag v3.6.6 replacing v3.6.5, indicating a small update to the page's revision history rather than substantive content changes.SummaryDifference0.1%

- Check78 days agoChange DetectedA new Revision: v3.6.5 tag appears in the page footer, replacing Revision: v3.6.4. This reflects a version update of the page/interface rather than a modification to the study details or user-visible content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.